These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15997348)

  • 21. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapidly Progressive Heart Failure in a Female Carrier of Becker Muscular Dystrophy with No Skeletal Muscle Symptoms.
    Komoriyama H; Fukushima A; Takahashi Y; Kinugawa S; Sera F; Ohtani T; Nakamura A; Sakata Y; Anzai T
    Intern Med; 2019 Sep; 58(17):2545-2549. PubMed ID: 31118394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerebral embolism associated with Becker muscular dystrophy-related dilated cardiomyopathy].
    Atsumi M; Tanaka A; Kawarabayashi T; Nishio S; Sakamoto H; Hasegawa T; Kitaguchi M
    No To Shinkei; 2004 Feb; 56(2):163-7. PubMed ID: 15098362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies.
    Kirchmann C; Kececioglu D; Korinthenberg R; Dittrich S
    Pediatr Cardiol; 2005; 26(1):66-72. PubMed ID: 15793655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Cardiac Imaging Approaches in Duchenne Muscular Dystrophy.
    Poonja S; Power A; Mah JK; Fine NM; Greenway SC
    J Clin Neuromuscul Dis; 2018 Dec; 20(2):85-93. PubMed ID: 30439754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
    Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
    J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac involvement in Becker muscular dystrophy: role of cardiovascular magnetic resonance.
    Vidal-Pérez R; Diaz-Villanueva J; Arzanauskaite M; Rojas R; Carreras F
    Eur Heart J Cardiovasc Imaging; 2013 Nov; 14(11):1038. PubMed ID: 23787066
    [No Abstract]   [Full Text] [Related]  

  • 28. Dilated cardiomyopathy as the initial presentation of Becker muscular dystrophy: a systematic review of published cases.
    Del Rio-Pertuz G; Morataya C; Parmar K; Dubay S; Argueta-Sosa E
    Orphanet J Rare Dis; 2022 May; 17(1):194. PubMed ID: 35549971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-compaction cardiomyopathy, Becker muscular dystrophy, neuropathy and recurrent syncope.
    Shah L; Tam I; Nosib S
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study.
    Walcher T; Steinbach P; Spiess J; Kunze M; Gradinger R; Walcher D; Bernhardt P
    Eur J Radiol; 2011 Oct; 80(1):115-9. PubMed ID: 20685051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
    Tandon A; Villa CR; Hor KN; Jefferies JL; Gao Z; Towbin JA; Wong BL; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
    J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of cardiac involvement in patients with limb-girdle type 2 and Becker muscular dystrophies: a 9-year follow-up study.
    Petri H; Sveen ML; Thune JJ; Vissing C; Dahlqvist JR; Witting N; Bundgaard H; Køber L; Vissing J
    Int J Cardiol; 2015 Mar; 182():403-11. PubMed ID: 25596466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
    Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
    J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A current approach to heart failure in Duchenne muscular dystrophy.
    D'Amario D; Amodeo A; Adorisio R; Tiziano FD; Leone AM; Perri G; Bruno P; Massetti M; Ferlini A; Pane M; Niccoli G; Porto I; D'Angelo GA; Borovac JA; Mercuri E; Crea F
    Heart; 2017 Nov; 103(22):1770-1779. PubMed ID: 28668906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
    American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
    Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results.
    Palladino A; Papa AA; Morra S; Russo V; Ergoli M; Rago A; Orsini C; Nigro G; Politano L
    Acta Myol; 2019 Mar; 38(1):1-7. PubMed ID: 31309174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
    Raman SV; Hor KN; Mazur W; Halnon NJ; Kissel JT; He X; Tran T; Smart S; McCarthy B; Taylor MD; Jefferies JL; Rafael-Fortney JA; Lowe J; Roble SL; Cripe LH
    Lancet Neurol; 2015 Feb; 14(2):153-61. PubMed ID: 25554404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patchy or homogenous myocardial fibrosis in Becker muscular dystrophy? Comments on Süselbeck et al., Z Kardiol 94:465-468/2005.
    Finsterer J; Stöllberger C
    Clin Res Cardiol; 2006 Apr; 95(4):244-5; author reply 245-6. PubMed ID: 16598596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.